When does the patent for acarbose expire?
The primary patent for acarbose, U.S. Patent 4,374,829, expired on August 14, 2001 [1].
What other patents are related to acarbose?
DrugPatentWatch.com tracks patents related to acarbose and its manufacturing processes. For a comprehensive list and analysis, users can consult resources like DrugPatentWatch.com [2].
How is acarbose manufactured?
Acarbose is a complex oligosaccharide produced through fermentation. The biosynthesis typically involves microbial strains that produce precursor molecules which are then enzymatically modified to yield acarbose [3].
What are the uses of acarbose?
Acarbose is a medication used to manage type 2 diabetes. It works by inhibiting alpha-glucosidase enzymes in the digestive tract, which slows down the breakdown of complex carbohydrates into glucose. This helps to reduce post-meal blood sugar spikes [4].
Who makes acarbose?
Acarbose is manufactured and marketed by various pharmaceutical companies worldwide. Generic versions are widely available [5].
What are the risks associated with acarbose?
Common side effects of acarbose include gastrointestinal issues such as diarrhea, flatulence, and abdominal pain, primarily due to the undigested carbohydrates fermenting in the colon [4].
Can acarbose be used for other conditions?
While primarily used for type 2 diabetes, research has explored acarbose's potential effects on other metabolic conditions, though its established use remains in glycemic control [4].
What is the regulatory status of acarbose?
Acarbose is an approved medication in many countries, including the United States and Europe, for the treatment of type 2 diabetes. Its approval involves rigorous clinical trials and regulatory review [4][6].
Sources:
1. U.S. Patent 4,374,829
2. https://drugpatentwatch.com/
3. A. L. Demain, "Industrial microbiology," ASM Press, 1999.
4. American Diabetes Association, "Acarbose," 2023.
5. FDA Orange Book, "Acarbose," 2023.
6. European Medicines Agency, "Acarbose Summary of Product Characteristics," 2023.